Science Explorer Back to mapMap
Discussion
Researcher · European Commission · Belgium

Ruxandra Draghia‐Akli

Ruxandra Draghia‐Akli publishes mostly in Infectious Diseases, Biotechnology and Genetics, on topics such as Microbial Inactivation Methods, Transgenic Plants and Applications and Virus-based gene therapy research.

ORCID 0000-0001-6372-4039 OpenAlex
World rank
#772,798
of 7,710,434 ranked researchers
Rank in Belgium
#7,062
of 67,186
Works
126
Citations
4.6k
Citations per work
36.2
h-index
34
i10-index 75Top 7.6% in Infectious Diseases
Ruxandra Draghia‐Akli

What does Ruxandra Draghia‐Akli research?

Ruxandra Draghia‐Akli's work is mostly in Biochemistry, Genetics and Molecular Biology (32%), Medicine (20%), Immunology and Microbiology (8%).

Life Sciences: 51 works · 40.3% of their workBiochemistry, Genetics and Molecular Biology: 40 works · 31.9% of their workBiotechnology: 16 works · 12.6% of their workGenetics: 13 works · 10.6% of their workMolecular Biology: 11 works · 8.7% of their workImmunology and Microbiology: 11 works · 8.4% of their workImmunology: 11 works · 8.4% of their workEverything else: 50 works · 39.9% of their workHealth Sciences: 25 works · 19.8% of their workMedicine: 25 works · 19.8% of their workInfectious Diseases: 19 works · 15.1% of their workEndocrinology, Diabetes and Metabolism: 6 works · 4.7% of their workTHEIR WORKRuxandraDraghia‐Akli126works
Life Sciences40%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology4031.9%
    2. Immunology and Microbiology118.4%
  2. Everything else5039.9%
    1. Medicine2519.8%
  1. 1Infectious Diseases15% of their works
  2. 2Biotechnology13% of their works
  3. 3Genetics11% of their works
  4. 4Molecular Biology9% of their works
  5. 5Immunology8% of their works
  6. 6Endocrinology, Diabetes and Metabolism5% of their works

Research topics

Which keywords describe Ruxandra Draghia‐Akli's research?

The keywords of their largest research topics: Gene Therapy, Immunity, SARS-CoV-2, Vaccine, Electroporation, Irreversible Electroporation, Epidemiology and AAV.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Gene Therapy452 topics
  2. Immunity292 topics
  3. SARS-CoV-2282 topics
  4. Vaccine282 topics
  5. Electroporation251 topic
  6. Irreversible Electroporation251 topic
  7. Epidemiology242 topics
  8. AAV201 topic
  9. Plant Molecular Farming201 topic
  10. Recombinant Proteins201 topic
  11. Viral Vectors201 topic
  12. Coronavirus161 topic
  13. spike protein161 topic
  14. IGF-1151 topic
  15. Insulin-like Growth Factors151 topic
  16. Cancer Immunotherapy131 topic
  17. Dendritic Cells131 topic
  18. Clinical Characteristics121 topic
  19. Norovirus121 topic
  20. Rotavirus121 topic
  21. Thrombosis121 topic

Where does Ruxandra Draghia‐Akli work?

Ruxandra Draghia‐Akli's main affiliation in the publication record is European Commission, Belgium.

How many publications and citations does Ruxandra Draghia‐Akli have?

OpenAlex counts 126 works and 4,555 citations for Ruxandra Draghia‐Akli, an h-index of 34, ranking #772,798 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ruxandra Draghia‐Akli. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.